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A B S T R A C T   
Fumagillin is a biomolecule produced by Aspergillus fumigatus that is gaining relevance due to its connection with 
invasive aspergillosis. The determination of this molecule might help to understand the propagation of this 
disease and study its use as a potential biomarker. In spite of the interest of fumagillin in microbiological 
research, no quantitative method has been developed so far for its determination in cell culture media. In this 
work, the first validated method for the quantitative analysis of fumagillin in RPMI-1640 is presented. The 
sample treatment consists of a mixed-mode anion exchange Solid Phase Extraction that effectively removes 
potential interferences and offered a recovery of 83 ± 7%. The analysis was carried out by Ultra High Perfor-
mance Liquid Chromatography coupled to Diode Array Detection at 336 nm. The method fulfilled the validation 
criteria established by EMA and FDA guidelines for bioanalysis (selectivity, carry over, linearity, accuracy, 
precision, dilution integrity and stability) and offers a limit of quantitation (25 μg⋅L− 1) suitable for its intended 
use. Indeed, the method was satisfactorily applied to the quantification of the fumagillin produced by three 
strains of Aspergillus fumigatus with different toxin production capacity.   
1. Introduction 
Fumagillin is a complex biomolecule produced by the fungus 
Aspergillus fumigatus. Soon after its discovery in 1949 [1] it was already 
studied as an antiparasitic drug against Nosema apis in honey bees [2]. In 
fact, the main application of fumagillin has been as an antibiotic to 
prevent microsporidiosis in honey [3] and fish [4] or to deal with other 
kind of parasites [5]. In humans, the uses of fumagillin are scarce. 
Among them, it has also been applied to treat microsporidiosis in 
immunocompromised patients, although severe adverse effects have 
been reported [6]. Another field in which this biomolecule proved to be 
of interest is the treatment of cancer. Due to its antiangiogenic effect, 
fumagillin and some of its derivatives have been studied as antitumoral 
drugs [7], but its use is not a common practice. 
According to recent studies, this mycotoxin might play an active role 
helping in the development of invasive aspergillosis [8–10]. Therefore, 
fumagillin is gaining relevance due to its potential application as a 
biomarker of this disease caused by A. fumigatus. Taking into account 
that this is one of the most important opportunistic fungal pathogens 
and that invasive aspergillosis has a mortality rate between 40% and 
90% [11], the early detection of this disease is a priority challenge. For 
that aim, the production of fumagillin by A. fumigatus and the interac-
tion of the mycotoxin with the target cells in the living organisms should 
be better understood. Therefore, analytical methodologies that can 
guarantee the reliable quantification of this biomolecule in matrices 
such as growth medium, biofluids or organs seem to be necessary. To the 
best of our knowledge, no quantitative method has been proposed yet 
for these matrices, apart from those that aim to carry out only a quali-
tative analysis of fumagillin [8,10,12]. 
The quantitative methods developed to date for the analysis of this 
mycotoxin are mainly addressed to matrices related to its use as an 
antibiotic, i.e. honey [13–20] and fish [21–23]. Nevertheless, some 
other matrices have been studied such as surface water [24] or dairy 
products [25]. The vast majority of these methods rely on reversed phase 
liquid chromatography coupled to diode array detection (DAD) 
[14,20–23,26] or mass spectrometry (MS) [14,15,18,19,24,25]. In spite 
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of the higher sensitivity of the MS methods, photometric detection has 
proved to offer suitable limits of quantitation (LLOQ) for the intended 
use, probably due to the high absorbance of fumagillin at relatively long 
wavelengths (335 and 350 nm) [5]. Regarding sample treatment, solid 
phase extraction (SPE) is usually the technique of choice after sample 
dilution with water or extraction with organic solvents. Most of the SPE 
approaches are based on reversed phase polymeric cartridges in which 
the molecule is retained due to hydrophobic interactions. However, 
Kanda et al. [17] demonstrated that mixed-mode anion exchange sor-
bents could be satisfactorily used to obtain a better clean up. 
Other important point to be taken into account during fumagillin 
analysis is its lack of stability under light exposure [27]. The molecule 
suffers from a fast degradation process that has been deeply studied. For 
instance, Assil et al. [20] observed that after one day of light exposure, 
only about one-third of the molecule remained in honey samples and 
Brackett et al. [26] estimated that only around 60% of the analyte 
remained after six hours of light exposure in acetonitrile solutions. The 
latter authors also discovered that while fumagillin is unstable when 
exposed to a 366 nm UV light, a 254 nm UV light did not degrade the 
molecule. This information is complementary to the one obtained by 
Garrett and Eble who observed that the photolytic degradation was 
minimal with light over 400 nm [27]. 
The aim of this work was to develop and validate an SPE-UHPLC- 
DAD method that would allow the reliable quantification of fumagillin 
produced by A. fumigatus in cell culture medium (RPMI-1640) for its 
subsequent application to study toxin release during host-fungus inter-
action assays using cell lines. 
2. Material and methods 
2.1. Reagents and materials 
Fumagillin (≥90%), sodium diclofenac used as internal standard (IS) 
and RPMI-1640, Dubelcós Modified Eaglés Medium (DMEM), Haḿs F12 
(HAMS) and Basal Medium Eagle (BME) cell culture media were pur-
chased from Sigma-Aldrich (St Louis, MO, USA). All these media were 
supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 
200 mM L-glutamine, 60 mg⋅L− 1 penicillin G, 100 mg⋅L− 1 streptomycin 
and 250 µg⋅L− 1 and amphotericin B. Furthermore, lysogenic broth (LB) 
(Panreac), glucose minimal medium broth (GMM) (a mixture of several 
salts and nutrients prepared as in Shimizu et al. [28]) and yeast-glucose 
broth (YG) (10 g⋅L− 1 glucose and 5 g⋅L− 1 yeast extract) were used. The 
solvents for UHPLC and sample preparation (methanol and acetonitrile) 
were supergradient grade and were obtained from Scharlau (Barcelona, 
Spain). Reagents used for buffer preparation were triflouoroacetic acid 
(TFA) (99%, Panreac), formic acid (LC-MS quality, Fluka), ammonium 
acetate (≥99%, Sigma-Aldrich), ammonium hydroxide, (25%, Merck), 
ammonium formate (≥99%, Fluka), citric acid hydrate (99.5%, Pan-
reac), sodium dihydrogen citrate (≥99%, Fluka), ammonium chloride 
(99.8%, Merck), trisodium phosphate (Merck, Pro Analysi) and sodium 
dihydrogen phosphate (Merck, Pro Analysi). Purified water was ob-
tained from a Millipore (Milford, MA, USA) Milli-Q Element A10 water 
system. Oasis MAX cartridges (1 cc, 30 mg) were purchased from Waters 
(Milford, MA, USA). 
2.2. Preparation of standard solutions and spiked RPMI-1640 samples 
Fumagillin was dissolved in ethanol to give a 1000 mg⋅L− 1 stock 
solution, which was stored at − 20 ◦C in amber vial. From this solution a 
20 mg⋅L− 1 working solution of fumagillin in acetonitrile was prepared 
and kept at − 20 ◦C. The rest of the working solutions of fumagillin were 
freshly prepared the day of the analysis. A 1000 mg⋅L− 1 stock solution of 
diclofenac (IS) was prepared in acetonitrile and, by diluting it, a working 
solution of 20 mg⋅L− 1 in acetonitrile was prepared and kept at − 20 ◦C. 
Spiked RPMI-1640 samples for sample treatment optimization were 
prepared by spiking drug-free RMPI-1640 with the 20 mg⋅L− 1 fumagillin 
working solution to a concentration of 200 μg⋅L− 1. Calibration standards 
at least at seven concentration levels ranging from 25 μg⋅L− 1 to 1500 
μg⋅L− 1 were prepared by dilution of the fumagillin working solutions 
with drug-free RMPI-1640. Quality control samples (QCs) for method 
validation were prepared by spiking RPMI-1640 with fumagillin work-
ing solution to four levels of concentration: 25 (LLOQ), 50 (LQC), 750 
(MQC), and 1200 (HQC) μg⋅L− 1. Additionally, dilution integrity was 
studied in a RMPI-1640 spiked at 5000 μg⋅L− 1. 
2.3. Degradation of fumagillin under light exposure 
Due to the fast photodegradation of fumagillin all the standards were 
prepared in amber vials [13]. Furthermore, the preparation of the so-
lutions and the sample treatment was carried out under red light 
exposure using red filters in order to minimize the degradation of the 
molecule. 
2.4. Chromatographic conditions 
Quantitative analysis of fumagillin was carried out on an Acquity 
Ultra Performance Liquid Chromatography system from Waters coupled 
to a diode array detector. The chromatographic separation was per-
formed on an Acquity BEH C18 column (2.1x50 mm, 1.7 μm) from 
Waters. In order to find the most suitable pH for the chromatographic 
separation, a linear gradient varying from 5% to 95% acetonitrile in 5 
min was applied to a 1 mg⋅L− 1 fumagillin sample (75:25, water:meth-
anol) using different aqueous mobile phases at pH 2 (TFA, 10 mM), pH 4 
(formic/formate buffer, 50 mM), pH 6 (citrate buffer, 50 mM), pH 8 
(ammonium acetate solution, 50 mM) and pH 10 (ammonium/ammonia 
buffer, 50 mM). 
The optimal chromatographic separation was achieved with a 50 mM 
ammonium/ammonia buffer (pH 10) as the aqueous mobile phase (A) 
and acetonitrile as the organic modifier (B). A flow rate of 0.40 mL/min 
was used with an elution gradient as follows: 0–0.5 min, 20% B; 0.5–5.5 
min, linear change from 20% to 95% B; 5.5–6.5 min, 95% B; 6.5–7.0 
min, from 95% to 20% B. A sample aliquot of 5 μL was injected into the 
column. During the chromatographic analysis, the column was ther-
mostated at 35 ◦C and samples were kept at 4 ◦C in the autosampler. 336 
and 280 nm wavelengths were employed for fumagillin and diclofenac 
(IS), respectively. The latter was chosen as IS due to the fact that is 
showed a proper chromatographic retention and a similar behavior as 
fumagillin during sample treatment. System control, data collection, and 
data processing were accomplished using Empower 2 software. 
2.5. SPE conditions 
For the sample treatment of RPMI-1640, a SPE treatment previously 
optimized by the research group was applied. In brief, the most adequate 
sorbent for SPE was chosen among several reversed phase cartridges 
(Oasis HLB, Waters; Strata-X, Phenomenex) and mixed mode cartridges 
(BondElute NH2, Agilent; Oasis MAX, Waters). In a latter step, the SPE 
procedure with Oasis MAX (Mixed-mode strong anion-exchange) car-
tridges was further optimized by experimental design. 
The optimal sample treatment conditions were established as fol-
lows: 500 μL of RMPI-1640 sample was spiked with 37.5 μL of 20 mg⋅L− 1 
IS solution in acetonitrile and 465 μL of phosphate buffer (100 mM, pH 
= 12). After vortex mixing the solution was transferred to Oasis MAX 
cartridges. The cartridges had been previously activated with 1 mL 
methanol and conditioned with 1 mL phosphate buffer (100 mM, pH =
12). After sample loading, the cartridges were washed with 1 mL 
phosphate buffer (100 mM, pH = 12):methanol (55:45). Then the car-
tridges were dried for 5 min at high vacuum and 1 mL of 3.5% formic 
acid solution in methanol was used for eluting the analyte. 500 μL of 
aqueous mobile phase were added to 500 μL of the eluate and after 
centrifugation, the solution was transferred to autosampler vials and 
subsequently injected into the UHPLC system for analysis. 
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In order to calculate the recovery of the sample treatment, five 
replicates spiked at 200 μg⋅L− 1 and a blank RMPI-1640 sample spiked 
after the SPE were analyzed. 
2.6. Validation of the analytical method 
Method validation was based on the European Medicine Agency 
(EMA) [29] and the Food and Drug Administration (FDA) [30] guide-
lines and was performed to evaluate the method in terms of selectivity, 
carryover, linearity, accuracy, precision, dilution integrity and stability 
of fumagillin in several conditions. 
The selectivity of the method was aimed to check the interferences at 
the retention time of the analyte and the IS by comparing the response of 
blank samples with a sample spiked with the IS and fumagillin at LLOQ. 
For acceptance, the signal obtained in the blank matrices must be lower 
than 20% the response of fumagillin at the LLOQ (5% for the IS). The 
regulatory agencies ask to study the selectivity at six different sources of 
the matrix in a scenario in which matrices with a high variability such as 
blood or urine are usually analyzed. The authors did not consider that 
analyzing six different sources of RPMI-1640 medium was necessary, 
and decided to apply the analytical method to other growth media 
instead. For his aim, we used three common cell culture media (DMEM, 
HAMS F12 and BME) as well as three standard microbiological broths 
(LB, GMM and YG). Furthermore, in order to study a potential inter-
ference the antimicrobial agents added to the cell culture media, stan-
dard solutions of 15 mg⋅L− 1 penicillin G, 25 mg⋅L− 1 streptomycin and 
72.5 µg⋅L− 1 amphotericin B in methanol:aqueous mobile phase (1:1) 
were chromatographically analyzed. 
Carryover was tested by the injection of a RMPI-1640 blank sample 
directly after the injection of a high concentration standard at a con-
centration of 5000 μg⋅L− 1. The response in the blank sample was 
compared with the response at the LLOQ, and was considered acceptable 
when the signal obtained at the fumagillin retention time was below 
20% of the signal at the LLOQ (5% for the IS). 
Calibration curves consisted of a blank RPMI-1640, a zero calibration 
standard and at least seven non-zero calibration standards spiked with 
fumagillin from 25 to 1500 μg⋅L− 1 in order to cover the expected range 
for the production of fumagillin by A. fumigatus. The calibration curves 
were built by plotting the corrected peak area of fumagillin against its 
nominal concentration. The acceptance criterion for the calibration 
curve was that the calculated concentration of at least six calibration 
standards should be ±15% of the nominal value (±20% for LLOQ). The 
LLOQ was defined as the lowest amount of analyte which can be 
quantified reliably complying with the criteria for accuracy and preci-
sion, and had been previously estimated from signal to noise ratio (S/N) 
and the analysis of several replicates in the 15–90 μg⋅L− 1 range. 
In order to evaluate the accuracy and precision, five replicates were 
prepared by spiking RMPI-1640 at four concentration levels of fuma-
gillin: 25 (LLOQ), 50 (LQC), 750 (MQC) and 1200 (HQC) μg⋅L− 1. For 
intra-day accuracy and precision five replicates of each concentration 
were analyzed the same day. These experiments were also repeated in 
three different days for the evaluation of inter-day accuracy and preci-
sion. The concentration value of the spiked samples was obtained from 
interpolation of the resulting corrected area in the regression equation. 
Accuracy was expressed as relative error (%RE), and precision was 
evaluated as relative standard deviation (%RSD). The acceptance cri-
terion for accuracy was that the mean value should be within ± 15% of 
the nominal value (20% for the LLOQ) and for precision was that %RSD 
must be ≤ 15% (20% for LLOQ). 
Dilution integrity was performed to ensure the reliable quantifica-
tion of samples greater than the upper limit of quantitation (ULOQ) after 
being diluted with blank matrix. For that aim RPMI-1640 spiked with 
fumagillin at a concentration of 5000 μg⋅L− 1 was diluted ten times with 
blank RPMI-1640 and analyzed. It was considered acceptable when both 
the %RE and %RSD were ≤15%. 
Stability assays of fumagillin under different conditions were carried 
out in spiked RPMI-1640 samples at low (50 μg⋅L− 1) and high (1200 
μg⋅L− 1) levels of concentration, using three replicates for each assay. 
Stability of spiked RPMI-1640 samples was tested following three 
freeze/thaw cycles, consisting each cycle on a 24 h period at − 20 ◦C 
before thawing; after 24 h in the autosampler at 4 ◦C; and after 2 months 
storage at − 20 ◦C. Furthermore, bench-top stability was assessed at two 
different conditions: four hours under red light exposure and four hours 
under regular laboratory light exposure. In this case, the same experi-
ment was carried out in a sample without matrix (i.e. water) in order to 
better understand the photosensitivity of the analyte. The concentra-
tions obtained under the different conditions were compared to the 
concentration of the same samples freshly prepared. The mean con-
centration at each level should be within ±15% of the nominal con-
centration to be considered stable. 
2.7. Application of the method to real samples 
The A. fumigatus Cea10 and ΔakuBKU80 reference strains were used in 
this study; furthermore, we included an environmental A. fumigatus 
strain (PB2021). The fungus was maintained on glucose minimal me-
dium agar (GMM) for seven days at 37 ◦C as previously described [31]. 
The conidia of the strains were obtained by harvesting and cleaning 
twice with saline-Tween solution (SS-T) (0.9% NaCl and 0.02% Tween 
20). 
To study the A. fumigatus fumagillin secretion ability 5 × 106 con-
idia⋅mL− 1 of each strain were seeded in 2 mL of RPMI-1640 using 6-well 
plates (ThermoFisher, Waltham, MA, USA). The plates were incubated at 
37 ◦C, 5% CO2 and 95% of humidity. After 48 h incubation period, 1 mL 
of the cultures was centrifuged at 14.000 rpm during 5 min to obtain the 
supernatant that was transferred to a light safe microtube and kept in ice 
until analysis. 
3. Results and discussion 
3.1. Chromatographic conditions 
Fumagillin determination is usually performed in reversed-phase 
columns at acidic pH values in which the carboxylic group of the 
molecule is protonated, favoring the retention in the chromatographic 
column of the neutral species [5]. Nevertheless, we observed that the 
best results in terms of peak shape and efficiency were obtained at 
higher pH values as can be observed in Fig. 1. Other authors have 
worked before at pH values in which fumagillin acidic group is in its 
anionic form [14]. Therefore, pH 10 was chosen as optimal value for the 
aqueous mobile phase and the gradient was fine-tuned in order to obtain 
a good retention factor for both the fumagillin and the IS. 
Fig. 1. Chromatograms obtained for 1 mg⋅L− 1 fumagillin solution using 
aqueous mobile phases at pH 2 (orange), pH 4 (red), pH 6 (green), pH 8 (blue) 
and pH 10 (black) under conditions explained in 2.4. 
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3.2. Recovery of the sample treatment 
Once the optimal parameters for SPE extraction were fixed, five 
RMPI-1640 samples spiked at 200 μg⋅L− 1 with fumagillin were analyzed 
and the response compared with the results obtained for a RPMI-1640 
blank sample spiked after extraction with 50 μg⋅L− 1. In this way, the 
obtained recovery was 83 ± 7%. 
3.3. Validation of the analytical method 
3.3.1. Selectivity 
In order to assess the selectivity of the method the chromatograms 
obtained for a RMPI-1640 blank and RPMI-1640 spiked at the LLOQ 
were studied. No interference were observed at the retention time of the 
analyte or the IS as shown for fumagillin in Fig. 2. 
Furthermore, another six media with different components were 
analyzed and, in spite of the complexity of some of them, none showed 
any significant interference at the retention time of the fumagillin or the 
IS (Fig. 3). It is especially remarkable the case of LB medium, which 
includes yeast extract, a fact that might explain the complex chro-
matogram obtained for this medium. Nevertheless, the analytical 
method proved to be selective enough also for this matrix thanks to the 
combination of the SPE extraction, the UHPLC separation and the choice 
of a proper detection wavelength. 
Finally, another important source of interferences in media analysis 
could be the antimicrobials employed for the cell culture. In order to 
study a potential interference, a standard solution of these compounds 
was injected and compared with a RMPI-1640 blank sample containing 
the antimicrobials that was subjected to the SPE treatment. As expected, 
streptomycin standard was not detected in the chromatographic analysis 
since it is not a suitable analyte for reversed-phase analysis coupled to 
photometric detection [32]. Regarding penicillin G and amphotericin B 
standards, their chromatographic response were observed at 0.9 and 2.1 
min, respectively (Fig. 4). Although in the RPMI-1640 sample 
Fig. 2. Chromatograms of a blank RPMI-1640 (grey) and RMPI-1640 spiked at 
25 μg⋅L− 1 (LLOQ) (black). The enlarged area shows the chromatographic signal 
for fumagillin. 
Fig. 3. Chromatograms obtained for the different growth media. The enlarged areas show the chromatographic signal for fumagillin.  
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chromatogram some compounds elute close to those retention times, the 
UV–Vis spectra clearly differ from the ones obtained for the antimicro-
bials. Therefore, those compounds are successfully removed during the 
sample treatment. Moreover, in the event of a potential retention of 
these antimicrobials in the SPE cartridge, the chromatographic method 
would allow to separate them from diclofenac (1.9 min retention time) 
and fumagillin (2.5 min retention time). 
3.3.2. Carryover 
No significant chromatographic peak at the retention time of fuma-
gillin was observed in the blank analyzed after injecting RPMI-1640 
spiked at 5000 μg⋅L− 1 with fumagillin. 
3.3.3. Linearity 
Calibration curves were obtained plotting the corrected area (ratio 
fumagillin area/IS area) for each concentration level versus the nominal 
concentration levels corresponding to each calibration solution. The 
calibration curves generated were fitted to a regression line by applying 
the lineal regression model based on the least square method. All of 
them met the criteria established for linearity from 25 to 1500 μg⋅L− 1 
with correlation coefficients ranging from 0.994 to 0.998. At least, six 
concentration levels with a %RE lower than 15% were used in each 
calibration curve and a heterogeneous distribution of the residuals was 
observed. 
3.3.4. Accuracy and precision 
The results obtained for accuracy and precision are shown in Table 1. 
The %RE and %RSD of the QC samples was lower than 15% at all con-
centration levels (both intra-day and inter-day). 
3.3.5. Dilution integrity 
From the replicates of the samples spiked at 5000 μg⋅L− 1 fumagillin 
concentration and then diluted and analyzed, a %RSD of 14.3% and a % 
RE of 13.0% were obtained, fulfilling the validation criteria for dilution 
integrity. 
3.3.6. Stability 
Fumagillin proved to be stable under all the studied conditions 
except for regular laboratory light exposure (Table 2). After 4 h under 
those conditions, an analyte loss of 31.0% (HQC) and 41.2% (LQC) was 
observed, far above the acceptable levels (15%). Thereby, the sample 
processing under red light exposure is strongly advisable in order to 
guarantee a more reliable quantitation. 
The degradation of fumagillin can be clearly observed in the chro-
matograms shown if Fig. 5. In those samples exposed to regular labo-
ratory light, fumagillin response decreases giving rise to at least two 
degradation products. These products are slightly more non-polar and 
showed a similar UV–Vis spectra as fumagillin. Photolytic degradation 
of fumagillin under similar conditions has been previously reported and 
associated to the appearance of new chromophores called neofumagillin 
(s). For instance, Brackett et al. [26] observed that around 40% of a 20 
mg⋅L− 1 fumagillin had been degraded after 6 h in acetonitrile and 
Kochansky and Nassr that 62% of a 42 mg⋅L− 1 fumagillin solution in 
50% ethanol had been degraded after 5.5 h [34]. On the contrary, 
Dmitrovic and Durden [19] only observed a degradation of 3% in a 10 
mg⋅L− 1 fumagillin solution in acetonitrile after 3 h. The same authors 
reported a complete degradation of the analyte under sunlight exposure. 
Thus, this difference might be explained by different conditions in lab-
oratory lighting. 
It is also noteworthy that the degradation in RPMI-1640 under 
fluorescence illumination was lower than the one observed on samples 
without matrix (i.e. in water): 68.7% and 56.6% for LQC and HQC, 
respectively (Fig. 5). Therefore, the presence of RPMI slows down the 
degradation of the analyte to some extent. 
3.4. Application of the method to real samples 
The analytical method was applied to study the ability to secrete 
fumagillin of three different strains of A. fumigatus. For that aim, the 
method was applied to the RMPI-1640 in which the strains had been 
cultivated for 48 h. As can be observed in Fig. 6, these strains produced 
different levels of fumagillin that could be successfully quantified: 150 
± 16 μg⋅L− 1 (Cea 10), 604 ± 52 μg⋅L− 1 (ΔakuBKU80) and 221 ± 23 μg⋅L− 1 
(PB2021). 
The variability in the production of the toxin by the different strains 
tested is significant and it is especially remarkable the high production 
of fumagillin by the ΔakuBKU80 mutant strain. This indicates that the 
mutation made in the nonspecific recombination system (ku70/ku80) of 
this fungus may have deregulated the secondary metabolism of this 
Fig. 4. Chromatogram obtained for RMPI-1640 blank (supplemented with the 
antimicrobial agents) after sample treatment (grey) together with the chro-
matograms of a penicillin G (PEN) and amphotericin B (AMP) standard solu-
tions (black). The chromatograms have been processed at maximum absorption 
wavelengths for those compounds: 210 nm (0–1.55 min) and 410 nm (1.55–3.0 
min), respectively. 
Table 1 
Intra- and inter-day accuracy and precision results (n = 3 days, 5 replicates) in 
terms of %RE and %RSD, respectively, at four concentration levels. For intra-day 
assays, apart from the mean value of the three days, the minimum (min) and 




















0.5  16.8 
50 (LQC) 4.1 (0.1–7.2) 11.5 
(7.5–14.8)  
4.0  11.6 
750 (MQC) 8.2 (7.3–9.6) 9.1 
(4.0–11.8)  
8.1  9.3 
1200 (HQC) 5.4 
(0.9–10.1) 
4.0 (1.7–5.6)  5.7  5.3  
Table 2 
Concentration variation percentage of the stability samples compared with a 
freshly prepared sample. The samples that show a significant statistic difference 
(p < 0.05) are noted (*).   
50 μg⋅L− 1 
(LQC) 
1200 μg⋅L− 1 
(HQC) 
Autosampler stability +7.3 − 0.6 
Freeze-thaw stability − 6.7 +2.9 
Long-term stability − 11.6 − 6.3 
Bench-top stability (regular light) − 41.2* − 31.0* 
Bench-top stability (red light) − 3.3 − 0.5  
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fungus. Since this strain is used in genetic studies for the generation of 
gene deletion mutants, this possible deregulation should be confirmed 
by the possibility of affecting nonspecifically the results of these genetic 
studies. In any case, it must be highlighted that the differences observed 
in the production of the toxin do not affect the reliability of the method 
as can be observed in Fig. 7. 
4. Conclusions 
Fumagillin is a mycotoxin that is gaining interest as a potential 
biomarker for invasive aspergillosis. In this scenario, quantitative 
methods as the one we propose in this research are necessary to carry out 
toxin release and fungal diagnosis studies. Even if several analytical 
methods have been developed for the determination of fumagillin in 
matrices such as honey or fish, this is, to our knowledge, the first vali-
dated quantitative method applied to cell cultures. The mixed mode 
anion exchange SPE allows a suitable cleaning-up of the matrix with a 
high recovery, which in combination with the UHPLC separation and the 
DAD detection provides a reliable method. In this way, the method has 
demonstrated to fulfill the requirements of the regulatory guidelines in 
terms of selectivity, carry over, linearity, accuracy, precision, dilution 
integrity and stability. Regarding the latter, one of the most important 
points to be taken into account during fumagillin analysis is minimizing 
light exposure to avoid photodegradation. In this aspect, the use of red 
light during sample treatment has demonstrated to be an appropriate 
measurement. 
The LLOQ values reported in literature for the analysis of fumagillin 
vary depending on the matrix and the detection method. Evidently, the 
methods based on mass spectrometry offer lower values ranging be-
tween 0.1 and 10 μg⋅Kg− 1. Regarding photometric detection, Fekete 
et al. obtained a 100 μg⋅Kg− 1 LLOQ in fish that could be improved to 5 
μg⋅Kg− 1 when a enrichment process is applied [21]. With DAD detection 
Nozal et al. obtained a LLOQ ranging from 95 to 150 μg⋅Kg− 1 depending 
on the botanical origin of the honey [14]. Therefore, the developed 
method offers a LLOQ (25 μg⋅L− 1) comparable or even better than other 
methods with photometric detection and, most importantly, shows to be 
enough for the intended use, as it has been satisfactorily applied to the 
analysis of fumagillin obtained from strains of A. fumigatus. Neverthe-
less, if a lower concentration of the analyte was to be determined, an 
evaporation and preconcentration step could be applied after SPE 
elution. 
The capacity to produce fumagillin has been related to the virulence 
capacity of the fungus as overexpression of the fumagillin production 
gene cluster has been detected during experimental animal infections 
[8]. Therefore, the determination of the production capacity of strains 
causing human infections is of high interest. In this work, we proved that 
the analytical method was applicable to strains producing very different 
amounts of the toxin. 
Regarding the results obtained from the analysis of different strains 
of A. fumigatus, a significant difference in the production of the toxin was 
observed. 
In conclusion, the method we present in this publication is an 
important step forward for the development of microbiological studies 
involving fumagillin and could help to better understand the role of this 
molecule in the propagation of invasive aspergillosis. It must be high-
lighted that, although the method has been optimized for its application 
in cell culture medium, it could be easily transferred to other matrices of 
interest such as plasma, urine or tissues. 
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